146 related articles for article (PubMed ID: 17159355)
1. Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cells.
Wu-Wong JR; Nakane M; Ma J
J Vasc Res; 2007; 44(1):11-8. PubMed ID: 17159355
[TBL] [Abstract][Full Text] [Related]
2. Effects of vitamin D analogs on the expression of plasminogen activator inhibitor-1 in human vascular cells.
Wu-Wong JR; Nakane M; Ma J
Thromb Res; 2006; 118(6):709-14. PubMed ID: 16371233
[TBL] [Abstract][Full Text] [Related]
3. VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells.
Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE
J Cell Biochem; 2007 Apr; 100(6):1395-405. PubMed ID: 17115413
[TBL] [Abstract][Full Text] [Related]
4. Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells.
Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE
Atherosclerosis; 2006 May; 186(1):20-8. PubMed ID: 16095599
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of vitamin d receptor agonists on gene expression in neonatal rat cardiomyocytes.
Wu-Wong JR; Chen YW; Nakane M; Wolf M
Cardiovasc Drugs Ther; 2011 Jun; 25(3):215-22. PubMed ID: 21424825
[TBL] [Abstract][Full Text] [Related]
6. Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells.
Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1592-604. PubMed ID: 17715259
[TBL] [Abstract][Full Text] [Related]
7. In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/β-catenin activation.
Martínez-Moreno JM; Muñoz-Castañeda JR; Herencia C; Oca AM; Estepa JC; Canalejo R; Rodríguez-Ortiz ME; Perez-Martinez P; Aguilera-Tejero E; Canalejo A; Rodríguez M; Almadén Y
Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1136-44. PubMed ID: 22874762
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of vitamin D analogs on vascular calcification.
Cardús A; Panizo S; Parisi E; Fernandez E; Valdivielso JM
J Bone Miner Res; 2007 Jun; 22(6):860-6. PubMed ID: 17352647
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D modulates tissue factor and protease-activated receptor 2 expression in vascular smooth muscle cells.
Martinez-Moreno JM; Herencia C; Montes de Oca A; Muñoz-Castañeda JR; Rodríguez-Ortiz ME; Díaz-Tocados JM; Peralbo-Santaella E; Camargo A; Canalejo A; Rodriguez M; Velasco-Gimena F; Almaden Y
FASEB J; 2016 Mar; 30(3):1367-76. PubMed ID: 26700731
[TBL] [Abstract][Full Text] [Related]
10. [Differential effect of vitamin D analogues on the proliferation of vascular smooth muscle cells].
Cardús A; Gallego C; Muray S; Marco MP; Parisi E; Aldea M; Fernández E
Nefrologia; 2003; 23 Suppl 2():117-21. PubMed ID: 12778867
[TBL] [Abstract][Full Text] [Related]
11. Effect of shear stress on the expression of coagulation and fibrinolytic factors in both smooth muscle and endothelial cells in a co-culture model.
Helenius G; Hagvall SH; Esguerra M; Fink H; Soderberg R; Risberg B
Eur Surg Res; 2008; 40(4):325-32. PubMed ID: 18303268
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor activators induce an anticalcific paracrine program in macrophages: requirement of osteopontin.
Li X; Speer MY; Yang H; Bergen J; Giachelli CM
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):321-6. PubMed ID: 19948844
[TBL] [Abstract][Full Text] [Related]
13. Calciotrophic hormones and hyperglycemia modulate vitamin D receptor and 25 hydroxyy vitamin D 1-α hydroxylase mRNA expression in human vascular smooth muscle cells.
Somjen D; Knoll E; Sharon O; Many A; Stern N
J Steroid Biochem Mol Biol; 2015 Apr; 148():210-3. PubMed ID: 25448744
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet.
Lau WL; Leaf EM; Hu MC; Takeno MM; Kuro-o M; Moe OW; Giachelli CM
Kidney Int; 2012 Dec; 82(12):1261-70. PubMed ID: 22932118
[TBL] [Abstract][Full Text] [Related]
15. Role of local versus systemic vitamin D receptors in vascular calcification.
Lomashvili KA; Wang X; O'Neill WC
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):146-51. PubMed ID: 24202304
[TBL] [Abstract][Full Text] [Related]
16. Ethanol inhibits pulse pressure-induced vascular smooth muscle cell migration by differentially modulating plasminogen activator inhibitor type 1, matrix metalloproteinase-2 and -9.
Cullen JP; Sayeed S; Kim Y; Theodorakis NG; Sitzmann JV; Cahill PA; Redmond EM
Thromb Haemost; 2005 Sep; 94(3):639-45. PubMed ID: 16268483
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease in chronic kidney failure: the role of VDR activators.
Wu-Wong JR; Tian J; Nakane M; Ma J; Fey TA; Kroeger P; Fryer RM; Reinhart GA
Curr Opin Investig Drugs; 2006 Mar; 7(3):206-13. PubMed ID: 16555680
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D analogs down-regulate plasminogen activator inhibitor-1 in human coronary artery smooth muscle cells.
Ruth Wu-Wong J; Nakane M; Ma J; Cook AL
J Thromb Haemost; 2005 Jul; 3(7):1545-6. PubMed ID: 15978119
[No Abstract] [Full Text] [Related]
19. High phosphate induces a pro-inflammatory response by vascular smooth muscle cells and modulation by vitamin D derivatives.
Martínez-Moreno JM; Herencia C; de Oca AM; Díaz-Tocados JM; Vergara N; Gómez-Luna MJ; López-Argüello SD; Camargo A; Peralbo-Santaella E; Rodríguez-Ortiz ME; Canalejo A; Rodríguez M; Muñoz-Castañeda JR; Almadén Y
Clin Sci (Lond); 2017 Jul; 131(13):1449-1463. PubMed ID: 28442557
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-α.
Aoshima Y; Mizobuchi M; Ogata H; Kumata C; Nakazawa A; Kondo F; Ono N; Koiwa F; Kinugasa E; Akizawa T
Nephrol Dial Transplant; 2012 May; 27(5):1800-6. PubMed ID: 22287655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
